Psoriasis and Pregnancy Update

Psoriasis is a chronic inflammatory disease affecting 1­–3% of the population, with 20–30% of patients requiring systemic treatment for moderate to severe disease, shares Kristine Kucera, PA-C. In this update on psoriasis and pregnancy, Kucera addresses the concerns women with psoriasis often face regarding pregnancy, including a lower pregnancy rate, the impact of treatments on pregnancy, and stigmatization, which leads many to delay pregnancy decisions. Treatment during pregnancy and postpartum requires careful consideration. Guidelines recommend specific therapies such as moisturizers and low-potency steroids while advising against teratogenic treatments like methotrexate and acitretin. Close collaboration between dermatologists and obstetricians is crucial for managing maternal and neonatal outcomes.